In June 2020, Zydus Cadila had received approval from Mexico#39;s regulatory authority Cofepris to test one of its lead research candidate Desidustat in the management of COVID-19.from Moneycontrol Business News https://ift.tt/3a6P2TE
Sunday, January 24, 2021
Zydus Cadila says #39;positive results#39; from phase 2 studies of COVID-19 drug Desidustat in Mexico
In June 2020, Zydus Cadila had received approval from Mexico#39;s regulatory authority Cofepris to test one of its lead research candidate Desidustat in the management of COVID-19.from Moneycontrol Business News https://ift.tt/3a6P2TE
Subscribe to:
Post Comments (Atom)
-
The value had touched a high of 22% of total market capitalisation of listed firms in June 2009, dropping to a low of 5.1% in September 2020...
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
No comments:
Post a Comment